| 今开：15.19 | 昨收：15.43 |
| 最高：15.19 | 最低：14.65 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.356106785E9 |
产业链观察01-30 06:46
#药闻简讯# 2024 年 1 月 29 日，$吉利德科学(GILD)$ 和 $Arcus Biosciences(RCUS)$ 生物科学公司今天宣布修订双方的合作协议，并由吉利德单独出资 3.2 亿美元，以每股 21.00 美元的价格购买 Arcus 普通股。 股权投资和合作协议的修订使两家公司跨越多个适应症的联合开发项目得以加速发展。 此外，...查看全文
Arcus Biosciences(RCUS)02-22 05:15
$Arcus Biosciences(RCUS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001724521-24-000050 Act: 34 Size: 368 KB 网页链接查看全文
Arcus Biosciences(RCUS)02-22 05:45
$Arcus Biosciences(RCUS)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001724521-24-000054 Act: 33 Size: 139 KB 网页链接查看全文
Arcus Biosciences(RCUS)03-30 04:25
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000071 Size: 5 KB 网页链接查看全文
Arcus Biosciences(RCUS)04-24 18:05
$Arcus Biosciences(RCUS)$ ARS Annual Report to Security Holders Accession Number: 0001724521-24-000083 Act: 34 Size: 16 MB 网页链接查看全文
Arcus Biosciences(RCUS)02-29 09:05
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000062 Size: 7 KB 网页链接查看全文
Arcus Biosciences(RCUS)02-29 09:05
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000063 Size: 7 KB 网页链接查看全文
Arcus Biosciences(RCUS)01-30 21:25
$Arcus Biosciences(RCUS)$ 8-K Current report, items 1.01, 3.02, 5.02, 8.01, and 9.01 Accession Number: 0001724521-24-000034 Act: 34 Size: 258 KB 网页链接查看全文
Arcus Biosciences(RCUS)02-09 21:45
$Arcus Biosciences(RCUS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-000970 Act: 34 Size: 8 KB 网页链接查看全文
Arcus Biosciences(RCUS)02-14 06:05
$Arcus Biosciences(RCUS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020321 Act: 34 Size: 12 KB 网页链接查看全文
智通财经APP获悉，今日，吉利德科学(GILD.US)和Arcus Biosciences(RCUS.US)在2023年美国临床肿瘤学会（ASCO）年会当中公布了针对转移性非小细胞肺癌（NSCLC）患者的2期临床试验ARC-7的最新中期分析结果。结果显示，在肿瘤高度表达PD-L1... 网页链接
格隆汇5月26日丨Arcus Biosciences (RCUS.US)涨11.43%，报19.5美元。瑞穗证券重申对Arcus Biosciences的”买入”评级，目标价51美元。 网页链接
$Arcus Biosciences(RCUS)$ ARS Annual Report to Security Holders Accession Number: 0001724521-24-000083 Act: 34 Size: 16 MB 网页链接
$Arcus Biosciences(RCUS)$ DEF 14A Other definitive proxy statements Accession Number: 0001724521-24-000079 Act: 34 Size: 2 MB 网页链接
$Arcus Biosciences(RCUS)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001724521-24-000081 Act: 34 Size: 361 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000071 Size: 5 KB 网页链接
$Arcus Biosciences(RCUS)$ 144 Report of proposed sale of securities Accession Number: 0001968582-24-000263 Act: 33 Size: 6 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000068 Size: 7 KB 网页链接
$Arcus Biosciences(RCUS)$ 144 Report of proposed sale of securities Accession Number: 0001724521-24-000065 Act: 33 Size: 7 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000063 Size: 7 KB 网页链接
$Arcus Biosciences(RCUS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000062 Size: 7 KB 网页链接
$Arcus Biosciences(RCUS)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001724521-24-000057 Size: 4 KB 网页链接